Presage Biosciences

BiotechnologySeries DSeattle, USpresagebio.com

Latest round

Series D

Last raised

Jul 2018

Total raised

$6M

Investors

2

About Presage Biosciences

Based in Seattle, US and founded in 2008, Presage Biosciences, Inc operates as a biotechnology company providing a new approach for evaluating drug responses in clinical trials. As of March 2021, Rich Klinghoffer is the CEO of the company.39 million. The company offers CIVO® (Comparative In Vivo Oncology) multiplexed intratumoral microdosing technology that allows clinical investigators to evaluate the localized tumor response to drug candidates in the tumor microenvironment along with capturing tumor heterogeneity and patient diversity. Also, the company plans to develop next-generation CIVO microdose injection devices designed to access a wider spectrum of cancers.

Who invested in Presage Biosciences

2 investors across 1 round

See all investors in Presage Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jul 17, 2018

    Amount

    $6M

    Investors

    Locked

Questions about Presage Biosciences

Who invested in Presage Biosciences?

Presage Biosciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Presage Biosciences raised?

Presage Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Presage Biosciences last raise money?

Presage Biosciences's most recent round on record is a Series D, in Jul 2018.

What does Presage Biosciences do?

Based in Seattle, US and founded in 2008, Presage Biosciences, Inc operates as a biotechnology company providing a new approach for evaluating drug responses in clinical trials.

Where is Presage Biosciences headquartered?

Presage Biosciences is headquartered in Seattle, US.

Which VCs invest in companies like Presage Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Presage Biosciences's stage. Their profiles are linked below.

Raising like Presage Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.